• contact
  • home
  • about
    • our history
    • management
    • board of directors
    • advisors
    • investors & partners
  • approach
  • pipeline
    • PRL-02
    • CGS-200-5
  • news & insights
    • news
    • presentations
    • press releases
    • references (PRL-02)
    • references (CGS-200-5)
  • contact
  • Menu

News: Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain

/in all, news /by neil

News coverage of our CGS-200-5 Phase 2 results for OA pain of the knee. Read Article

Read more
https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg 0 0 neil https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg neil2019-12-18 17:49:002020-05-05 19:54:24News: Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain

Pages

  • about
  • approach
  • CGS-200-5
  • contact
  • copyright policy
  • home
  • news & insights
  • our history
  • pipeline
  • privacy policy
  • terms of use
  • management
  • board of directors
  • PRL-02
  • advisors
  • investors & partners

Categories

  • all
  • news
  • presentations
  • press releases
  • references (CGS-200-5)
  • references (PRL-02)

Archive

  • June 2021
  • May 2021
  • February 2021
  • January 2021
  • June 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • July 2018
  • June 2018
  • home
  • about
  • approach
  • pipeline
  • news & insights
  • contact
© 2020-2021 Propella Therapeutics, Inc. / all rights reserved
  • privacy policy
  • terms of use
  • copyright policy
Scroll to top